Key Takeaways
- Revenue growth held at 16% Y-o-Y in Q4, but employee costs surged to 53% of revenue and attrition hit unprecedented levels above 30%, compressing near-term margin expansion.
- Annuity and subscription revenues are building a more predictable base: annuity revenue grew 18% Y-o-Y to 59% of total, while cloud/subscription bookings promise further assurance, with the mix expected to cross 60-65% in 3-5 years.
- The GSI channel is gaining traction but remains early-stage: partner revenue share rose to ~23% and the GSI funnel doubled, yet closure cycles are long and management does not expect the GSI mix to materially shift margin dynamics next year.
- Management is explicitly prioritizing growth investment over margin expansion: sales and marketing costs are set to return to pre-pandemic levels of 25-30% of costs, and PAT margins are guided to a narrow 18-19% band for FY23.
- What to watch next quarter: whether attrition actually begins to normalize toward Q3/Q4 as management expects, the pace of GSI revenue conversion from a doubled funnel, and any stabilization in the US business after lapping a one-time ~₹25 Crores PPP revenue headwind.
Cost Normalization & Margin Pressure
- Employee cost spike: Employee cost rose to 53% of revenue from 49% last year, driven by normalization of a previously depressed cost base, increased remuneration to manage attrition, and demand-driven pressure. Last year's costs were abnormally low because many business activities were not happening.
- Further pressure ahead: Employee cost is expected to go up by a few more percentage points in FY23 as the company works through the new reality of normalizing costs across all channels.
- Attrition at historic highs: Attrition levels are above 30%, possibly touching close to 40% for FY22, percentages never seen in the company's history. Management plans to bring attrition down significantly in FY23 and expects normalization in Q3 or Q4, citing early signs of stabilization this quarter.
- SG&A rising: Other expenses increased because of investments in sales and marketing toward the later part of the year as markets opened up, office reopening expenses, and some travel resumption including events and business travel.
- Travel costs returning: Travel has resumed, with significant travel on sales and marketing, events, and other business travel in the current quarter. Travel cost is expected to rise from current levels but not to touch 10% of revenue in the next 2-3 years, staying around 3-4% of revenue.
- PAT and EBITDA guided to narrow bands: Management expects to deliver PAT margins between 18% to 19% and EBITDA margins around 23% for FY23, explicitly stating that operating margin expansion may not be practical for next year because base costs are very high and there will be additional cost next year.
Virender Jeet: "We think the employee cost further to go up even coming in this year by a few more percentages, but over a longer period of time you are absolutely right, a lot of our growth has got very little to do with direct cost involvement as you are rightly saying around 50% of our revenue has got no direct costs. We should be able to expand the margin, but in the near term right now we are working on the new reality of normalizing costs across all channels, so there is going to be some more pressure on the employee cost side."
Revenue Mix Shift: Annuity & Subscription
- Annuity revenue growing faster than total revenue: Annuity revenues grew 18% Y-o-Y to ₹456 Crores, now constituting 59% of overall revenues, providing a more predictable base.
- Cloud and subscription acceleration: Cloud and subscription revenues grew 23% Y-o-Y, with large cloud and subscription order bookings leading to more assured future revenue. The first cloud orders from the Australian market were received this year, with revenues to start from next year onwards.
- Subscription mix target: Management estimates that subscription revenue should hit more than 60-65% of overall revenue in the next 3-5 years, growing at a higher pace than overall growth rates as the company shifts organically from license-based to subscription-based business.
- Customer count declined on mix shift, not weakness: Active customer count fell from ~550-560 to ~530 because (1) during the pandemic, ATS/AMC renewals from smaller customers did not happen, causing churn at the lower end, and (2) new business shifted to subscription model, so previously license-based revenue recognition is now spread over time, reducing the number of customers contributing revenue in a given year.
- Order book strength undisclosed: Management stated the overall order book is "much, much higher" than revenue and backlog growth this year is higher than revenue growth this year, but declined to share specific backlog numbers, expecting to provide backlog, deferred orders, and ARR for subscription in the next 3-4 quarters.
Virender Jeet: "Our estimates are that next three to five years, our subscription revenue should hit more than 60%, 65% of our overall revenue, this is the one head which keeps on going at a higher pace than our growth rates and as we are reaching more and more for subscription and removing the license based business organically we should further escalate."
Geographic Performance: EMEA Outshines, US Stable ex One-Time
- EMEA delivered standout growth: EMEA did far better this year for two reasons: the market is looking very healthy, with significant business in the Middle East depending on oil prices and a healthy environment, and growth is on the base of very low growth last year due to the oil shock.
- EMEA margin expansion: Since most costs are attributed in India, top-line growth expands margin significantly. EMEA margins look much better because of 40% growth; if territory growth is higher than average company growth, margins will continue to expand.
- US revenue stable after lapping one-time PPP benefit: US last year included a one-time paycheck protection program revenue of more than ₹25 Crores; the company maintained momentum and compensated for that. Profit before tax in the US business fell sharply because the one-time revenue did not recur, and base costs rose while top-line growth only compensated for the missing revenue.
- APAC and India returned to growth: Growth has been broad-based; APAC and India have come back to growth momentum.
- Mature market penetration remains the long-term challenge: Management acknowledged that the company is a small fraction of the overall addressable market and that the fraction will not change unless it makes a big dent in markets like the US and Europe, with significant change expected in the next 2-3 years if sales and marketing initiatives succeed.
Virender Jeet: "You are right if you look at overall addressable market we are a small fraction of that but I do not think that that fraction will change unless you make a big dent in markets like US and Europe."
GSI Channel & Partner Strategy
- Partner revenue share rising: Partner revenue share grew from ~17-18% to ~23% of revenue.
- GSI funnel doubled: The GSI funnel doubled from ~40 to 70-80 cases, though GSI closure cycles are longer than direct deals. Revenue accumulation from GSI is expected in coming quarters and years, and the company is still far from its 50% partner revenue target but moving in a positive direction.
- GSI deal economics: GSI deals are slightly larger in nature than the average deal size, with an expectation that these accounts should have the potential to build from $500K of annuity to ~$1M of annuity over a period of time.
- Near-term margin impact limited: Management does not expect the implementation mix to shift so much to GSI next year that it changes the overall dynamics of the margin. Over time, margin expansion should happen through the GSI shift, but investments for growth will balance it.
- Growth ambition tied to GSI execution: The company expects to escalate historical growth rates of ~20% by adding momentum from larger Fortune 2000 clients via GSI. Whether growth reaches 25% or 35% depends on how successfully the company executes its plans, including GSI.
Virender Jeet: "We have a responsibility also to invest for growth for the company and will continue to invest for growth and those investments would balance it. So you are right the margin expansion should happen through that as well, but for next year we do not think that the implementation will move so much to GSI that it will change the overall dynamics of the margin."
Investment Priorities: Sales & Marketing Over R&D
- Sales and marketing spend returning to pre-pandemic levels: Sales and marketing costs, currently at 20% of revenues, are expected to go back close to the pre-pandemic range of 25-30% of costs, and can even grow higher as the company grows in mature markets.
- R&D spend stable: R&D is at ~10% of revenue and is not expected to change drastically; it may range between 9.5% to 11% this year and next year unless a huge opportunity emerges. Whether R&D is 6%, 10% or 15% is determined by the opportunity seen across the horizon.
- Growth investment prioritized over margin expansion: Management is explicit that it has a responsibility to invest for growth and will continue to do so, looking at growth coming from top line and expansion of business over the next three to four years, hopeful of substantially changing the numbers for the company.
- Operating leverage potential: Any growth in the business beyond the historical trend rate of 15-20% significantly expands margins, but near-term investments will absorb that leverage.
- Cash deployment plans: The company is looking at both inorganic and organic ways to deploy ~₹460 crores of cash for growth over the next few years. If further excess cash remains in 1-2 years, it may increase dividend payouts, but no firm acquisition plans or target numbers exist yet.
Virender Jeet: "Product company with always works with this hope that the hockey stick is just around the corner and I think the hockey stick has got nothing with margins if you look at the gross margin level we still operate around 70% gross margin, so which is as high as it gets, we can go up to 75% but I do not think that is worth it, but I think we are looking at growth coming from the top line and the expansion of the business and that is where we expect an hockey stick."
Product & Platform Developments
- Number Theory acquisition: Acquired Number Theory in January, an AI/ML platform that uses a low-code approach for modeling, to strengthen the NewgenONE platform with AI/ML modeling and data analytics capabilities. The acquisition is reflected in intangible assets of ₹16 Crores and goodwill of ₹2.5 Crores on the balance sheet, with intangibles to be amortized over the next five years.
- Platform augmentation: The AI/ML platform will be used to augment current vertical solutions in banking and other areas, and horizontal products, extending functionality and potentially providing an additional horizontal product in the AI/ML space.
- Patent portfolio growth: Patent portfolio grew to 23 grants across key content services technologies.
- Analyst recognition: Received additional recognition from Gartner and Forrester during the year.
- Banking product opportunity: Banking products, including lending and trade finance accelerators, are opening up opportunities for larger deal sizes, with the company expecting to capitalize in coming years.
- Key Q4 wins: Enterprise transformation deal for a leading housing finance company and a leading private sector bank in India; large project win for a leading privately-owned Philippines commercial bank; projects for a leading omnichannel fintech company delivering digital financing solutions in Saudi Arabia; project for a federal government entity in UAE managing federal budget and regulation.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| PAT margin | Deliver between 18% to 19% | FY23 |
| EBITDA margin | Around 23% | FY23 |
| Attrition normalization | Bring attrition down significantly from 30%+ levels | Q3, Q4 of FY23 |
| Subscription revenue mix | Hit more than 60-65% of overall revenue | Next 3-5 years |
| Backlog and ARR disclosure | Provide backlog, deferred orders, and ARR for subscription | Next 3-4 quarters |
| Sales & marketing costs | Return close to pre-pandemic levels of 25-30% of costs | FY23 and beyond |
| R&D spend | Remain around 10% of revenue, ranging 9.5% to 11% | FY23 and next year |
| Cash deployment | Deploy ~₹460 crores for growth via inorganic and organic means; if excess remains, may increase dividend payouts | Next 1-2 years for dividend decision |
Key Metrics
| Metric | Q4 FY22 |
|---|---|
| Revenue | ₹232 cr, +16% YoY |
| FY22 revenue | ₹779 cr |
| EBITDA | ₹67 cr, stable |
| FY22 EBITDA | ₹195 cr, stable |
| Profit after tax | ₹57 cr |
| FY22 profit after tax | ₹164 cr, +30% YoY |
| PAT margin expectation (FY23) | 18% to 19% |
| EBITDA margin expectation (FY23) | about 23% |
| Annuity revenue (FY22) | ₹456 cr, +18% YoY, 59% of overall revenue |
| Cloud and subscription revenue growth (FY22) | 23% YoY |
| Subscription revenue share (FY22) | 31% of total revenues |
| Gross margin | around 70% |
| Partner revenue share (FY22) | roughly 23%, up from 17%–18% previous year |
| GSI funnel | 70 to 80 cases, up from around 40 cases last year-end |
| Customers with billing over ₹5 cr (FY22) | 38, up from 26 in FY21 |
| New logos added (FY22) | 53 |
| Active customers | roughly 530, down from 550–560 range previously |
| Attrition (FY22) | above 30%, may be touching close to 40% |
| Employee cost (FY22) | 53% of revenue, up from 49% last year |
| R&D expense (FY22) | about 10% of revenue |
| Sales and marketing expense (FY22) | 20% of revenues |
| Cash, bank balance and investments | ₹462 cr |
| Net cash from operating activities (FY22) | ₹143 cr |
| Net trade receivables | ₹279 cr, net DSO of 131 days |
| Dividend payout ratio (FY22) | 45% |
| US one-time PPP revenue (FY21) | ₹25 cr, not repeated in FY22 |
| EMEA segment growth (FY22) | 40% kind of growth |
| Intangible assets from Number Theory acquisition | ₹16 cr product valuation, ₹2.5 cr goodwill, amortized over 5 years |